One of Canada’s highest awards of honour has some familiar Dal faces among its latest batch of appointees.

Gaining global influence as a researcher can be tough to pull off as a solo endeavour. Collaborations, particularly those that cross borders, are key.

For many Black students, the journey to medical school is marked by ambition, resilience, and sometimes, isolation. The launch of a new bursary is helping to change that narrative—offering not only financial support, but a sense of belonging.

The first of its kind in the Maritime provinces, the MPAS provides graduates with the competencies needed to provide compassionate, evidence-based care and significantly contribute to interprofessional healthcare teams, alleviating some of the burdens faced by our healthcare system.

An international exchange program is immersing Dalhousie medical students in a world-class academic and clinical environment—nearly 6,000km from Halifax.

Dalhousie's contributions to science and innovation were front and centre Thursday (Nov. 20) at the 23rd annual Discovery Awards in Halifax as its researchers scooped up four awards.

A national study led by a Dalhousie researcher aims to better understand how biological and social factors can influence health outcomes for Canadians living with multiple sclerosis (MS).

From celebrating cultural traditions to shaping inclusive policies, the Department of Pathology’s Equity, Diversity, Inclusion, and Accessibility (EDIA) Committee is redefining what equity and belonging look like in medical education.

Dr. John Embil (MD ‘89) grew up in a Halifax household steeped in science and service. His father, a Cuban immigrant, Dalhousie faculty member, infectious diseases consultant and virologist, laid the foundation for a life devoted to infectious diseases.

Developed by Drs. Gabriela Ilie and Rob Rutledge at Dalhousie University, PC-PEP is a six-month, science-based, daily intervention program designed to empower patients with prostate cancer to take charge of their health and well-being.